0001628280-23-042492.txt : 20231221
0001628280-23-042492.hdr.sgml : 20231221
20231221160427
ACCESSION NUMBER: 0001628280-23-042492
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231220
FILED AS OF DATE: 20231221
DATE AS OF CHANGE: 20231221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Almenoff June Sherie
CENTRAL INDEX KEY: 0001492647
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37590
FILM NUMBER: 231505288
MAIL ADDRESS:
STREET 1: C/O BRAINSTORM CELL THERAPEUTICS INC.
STREET 2: 1325 AVENUE OF AMERICAS 28TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avalo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001534120
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 450705648
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 410-522-8707
MAIL ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: Cerecor Inc.
DATE OF NAME CHANGE: 20111102
4
1
wk-form4_1703192659.xml
FORM 4
X0508
4
2023-12-20
0
0001534120
Avalo Therapeutics, Inc.
AVTX
0001492647
Almenoff June Sherie
C/O AVALO THERAPEUTICS, INC.
540 GAITHER ROAD, SUITE 400
ROCKVILLE
MD
20850
1
0
0
0
0
Stock Option (Right to Buy)
0.043
2023-12-20
4
A
0
3334
0
A
2024-12-20
2033-12-20
Common Stock
3334
3334
D
The stock option will vest in full on December 20, 2024, subject to the Reporting Person's continued service on such vesting date.
/s/ Jennifer Zoltoski, by Power of Attorney
2023-12-21